|
Index of reports
> Cases resulting in hospitalization (56)
> Cases with Drug Exposure During Pregnancy (8)
Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in hospitalization where reactions include drug exposure during pregnancy.
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-30
Patient: female, weighing 3.9 kg (8.6 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Drug Administration Error, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Zidovudine
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-29
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Combivir
Indication: Antiviral Prophylaxis
Start date: 2005-02-17
End date: 2005-04-06
Retrovir
Dosage: 1.1ml twice per day
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2005-04-06
End date: 2005-05-17
Other drugs received by patient: Retrovir; Kaletra
Adverse event in receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient:
Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: HIV Infection
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Morphine
Retrovir
Indication: HIV Infection
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Viracept
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: Antiviral Prophylaxis
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Adverse event in 28 month old female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29
Patient: 28 month old female
Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: from the 17th week of gestation to the 26th week.
Start date: 1997-11-01
End date: 1998-04-01
Epivir
Dosage: syrup
Administration route: Oral
Start date: 1997-11-01
End date: 1998-01-01
Invirase
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Norvir
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Retrovir
Dosage: from the 13th week to the 26th week of gestation.
Start date: 1997-10-01
End date: 1998-01-01
Retrovir
Dosage: syrup
Administration route: Oral
Start date: 1997-10-01
End date: 1998-01-01
Videx
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Zerit
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12
Patient: male
Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Epivir
Dosage: transplacentary
Indication: HIV Infection
Nevirapine
Dosage: transplacentary
Indication: HIV Infection
Retrovir
Dosage: oral
Administration route: Oral
Retrovir
Dosage: transplacentary
Indication: HIV Infection
Stavudine
Dosage: transplacentary
Indication: HIV Infection
Adverse event in 6 month old male receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-01-25
Patient: 6 month old male, weighing 2.5 kg (5.5 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Epivir
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Marijuana
Retrovir
Dosage: .38ml per day
Start date: 2004-09-23
End date: 2004-09-24
Retrovir
Administration route: Oral
Start date: 2004-09-26
End date: 2004-11-18
Retrovir
Dosage: .7ml three times per day
Administration route: Oral
Start date: 2004-10-26
End date: 2004-11-18
Retrovir
Dosage: 300mg per day
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Viracept
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Viracept
Dosage: 280mg twice per day
Administration route: Oral
Start date: 2004-10-26
End date: 2004-11-18
Viramune
Start date: 2004-09-22
End date: 2004-09-23
Other drugs received by patient: Viramune; Bactrim; Espo; Glucose; Glucose
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-01-19
Patient: male
Adverse reactions / side effects: Paresis Cranial Nerve, Vomiting, Visual Acuity Reduced, Neoplasm, Somnolence, Strabismus, Papilloedema, Diplopia, Pinealoblastoma, Fatigue, Drug Exposure During Pregnancy, Hydrocephalus
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 1998-04-28
End date: 1998-06-05
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 1998-04-28
End date: 1998-06-05
Other drugs received by patient: Retrovir; Epivir; Retrovir; Clamoxyl
|
